SAN JOSE, Calif., Dec. 2, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the ...
News
- Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium
- Anixa Biosciences Inc (NASDAQ:ANIX)'s Stock Is Sell After More Market Selling
The stock of Anixa Biosciences Inc (NASDAQ:ANIX) registered an increase of 1.06% in short ... The short interest to Anixa Biosciences Inc's float is 6.86%. ... “Anixa Bio teams up Urology San Antonio for Cchek prostate cancer study ...
- Making seeds to withstand climate change is getting harder
If such information ended up on a public database, anyone-even biotech or pharmaceutical companies-could use it without any obligation to pay into ...
- Global Microbiome Therapeutics Market, Top key players are ENTEROME Bioscience, Rebiotix ...
Top key players are ENTEROME Bioscience, Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, ... 1604 W San Antonio,.
- Drug designed and manufactured for 9-year-old Boulder girl
She is initiating talks with the National Institutes of Health, the largest public funder of biomedical research, as well as research institutions, the FDA ...